Although IGF-1<-2SD and hypogonadism did not retain significance in the height-adjusted model, their high-risk associations in the uncorrected model suggest that growth hormone axis dysfunction and gonadal hormone deficiency remain potential underlying drivers of bone loss in TDT patients. This evidence concerns the gene GH1 and hypogonadism.